id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-336543-ydrmlujj	Cavalli, Eugenio	Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)	2020-06-25		.txt	text/plain	5813	260	39	We propose here that the thromboembolic events and eventually the development of DIC provoked by SARS-CoV-2 infection may represent a secondary anti-phospholipid antibody syndrome (APS). On the basis of empirical observations and emerging laboratoristic findings, we will elaborate the hypothesis that several cases of thrombotic events during cOVId-19 infection represent the clinical epiphenomenon of a viral-induced secondary anti-phospholipid antibody syndrome (APS) that, in the most severe cases, may develop as catastrophic anti-phospholipid antibody syndrome (cAPS). clinical evidence and emerging data from pathological examinations indicate that a thrombotic diathesis, potentially leading to venous thromboembolism (VTE), and to dIc in some of the most severe cases, may occur in a substantial proportion of patients with cOVId-19 infection, also in a manner independent of long-term bed rest and eventual hormonal treatment.	./cache/cord-336543-ydrmlujj.txt	./txt/cord-336543-ydrmlujj.txt